Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade ...

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...

As Independence prepares to vote on maintaining a four-day school week, parents and teachers say the impact on their ...

A congressional report uses Purdue University as a case study to argue for tighter limits on Chinese students and academic ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...

Meet the teacher who turned his hatred of school into a passion for educating the next generation of Bronx students. His ...

BANGKOK (AP) — China has commissioned its latest aircraft carrier after extensive sea trials, state media reported Friday, ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsJonae Barnes - Senior Vice President of ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Discover a practical blueprint for building a modern, intelligence-driven threat program aligned with enterprise risk and ...